Pelican-Cancer-Foundation-logos
Donate Now
Search
Pelican-Cancer-Foundation-logos

Dedicated to helping patients with bowel and liver cancer live well for longer

Donate Now
Search
  • Home
  • About us
    • About us
    • What we do
      • Our achievements
      • The Future
    • Who we are
      • Trustees
      • Our Team
      • Patrons
      • Annual Accounts
    • Partnerships
    • Vacancies
    • News
  • Education
    • Pelican OReCO
      • OReCO On-line Resources
      • OReCO Partners & Sponsors
      • Pelican OReCO Workshops
    • Pelican IMPACT
      • IMPACT – Completion & Evaluation
      • Workshops
      • IMPACT – Online resources
      • IMPACT – Partners and Sponsors
    • SPECC
      • SPECC – Completion & Evaluation
      • Workshops
      • SPECC – Online resources
      • SPECC – Partners and Sponsors
    • LOREC
    • TIPTOP
      • Workshops
      • TIPTOP – Online resources
      • Bob’s story (prostate cancer)
      • Andrew’s story (prostate cancer)
      • Alan’s story (prostate cancer)
      • Raymond’s story (prostate cancer)
    • LARS
    • Sponsors
      • Become a sponsor
    • Request a course or topic
    • Give us feedback
    • Previous courses
  • Films
  • Research
    • MERCURY 3
    • Research strategy
    • Bowel cancer research
      • POLARS
      • MERCURY 2 (Low Rectal Cancer Study)
      • Deferral of surgery study
      • TATME
      • IMPRESS
      • TRIGGER
      • Papers of interest
      • Timing of surgery
      • AMSOEC
      • MINSTREL
      • Completed research
        • Perineal wound healing registry
        • Beyond TME
        • Validation of the LARS score
        • MARVEL: Evaluation of EMVI positive rectal cancer
        • FLEX
        • TME Physical Simulation Model
        • Total Mesorectal Excision (TME)
        • MERCURY research programme
    • Liver cancer research
      • Completed research
        • EORTC studies
      • SERENADE
      • Papers of interest
    • Peritoneal malignancy research
      • Colorectal Peritoneal Malignancy Database
      • Pseudomyxoma Pathology Atlas
    • Previous Research Areas
      • Prostate Cancer Research
        • Prostate cancer
        • Focal therapy and HIFU research
        • MRI research for prostate cancer
        • Prostate cancer colloquiums
        • FORECAST
        • Trachtomap
        • Papers of interest
      • Bladder cancer research
        • Bladder cancer
        • Papers of interest
    • Peer reviewers
    • Clinical trials
    • Information for research applicants
      • Peer Review Panel Terms of Reference
      • Research Review Panel
      • Research Grant Application Guidance Notes
      • Terms and conditions of grants
      • Animals in medical research
      • Research costs
    • Surgical videos
  • For Patients
    • Patient stories
      • Anthony’s story (bowel cancer)
      • Elena’s story (bowel cancer)
      • Terry’s story (liver cancer)
      • Derrick’s story (liver cancer)
      • Alex’s story (colorectal cancer)
      • Cheryll’s story (rectal cancer)
      • Eileen’s story
      • Richard’s story – irrigation
      • Tom’s story – complete response
      • Advanced metastatic bowel cancer
    • What is an MDT?
      • What an MRI reveals
      • Reporting cancer outcomes
    • Bowel cancer
      • Our bowel cancer team
      • About bowel cancer treatment – TME
      • April – Bowel Cancer Awareness Month
      • Low rectal cancer
      • Complete response to chemoradiotherapy in rectal cancer
      • Frequently asked questions about bowel cancer
      • Irrigation for colostomies
      • A patient’s advice
      • Symptom checker
      • Bowel cancer – useful contacts
    • Liver cancer
      • Our liver cancer team
      • About liver cancer treatment
      • Interventional radiology
      • Liver cancer – frequently asked questions
      • Carcinoid and neuroendocrine tumours
      • Liver cancer – want to read more?
    • Pseudomyxoma peritonei
    • Getting a second opinion
    • Clinical trials
      • Current clinical trials
    • Tell us your story
    • Still got questions about cancer?
    • Links
  • Support us
    • Make a donation
      • Make a donation
      • Shares
      • In memory
    • Fundraise for us
      • Our fundraisers
      • Fundraising ideas
      • Fundraising challenges
      • Fundraising resources
    • Leave a Gift in your Will
    • Become a Corporate Partner
    • Trusts, Foundations & Philanthropy
    • Tell us your story
  • Contact us

POLARS

Pre-operatively Predict The LARS Score

POLARS, or the Pre-Operative Low Anterior Resection Syndrome Score, is a mathematical model, accessed by the internet that has been designed to help patients and doctors understand the risk of poor bowel function after rectal cancer surgery. You can see a short video here and a pdf document here. There is also a longer video presentation here with accompanying audio.

The interactive POLARS tool is easy to use. Simply input an individual’s data for the variables shown below and press calculate.

The POLARS webpage does not collect or store any personal information.

Please enter the following:
Age at surgery:
Gender:
TME / PME:
Tumour height (cms):
Stoma?
Pre-op radiotherapy:
Results:
LARS score: …

 

How should I interpret the POLARS score?

POLARS, the pre-operative LARS score, is presented as a single value Battersby et al, (1). It is a prediction of the symptoms reported according to a bowel function questionnaire called LARS (2). The cut off values of 0 to 20 (no LARS), 21 to 29 (minor LARS), and 30 to 42 (major LARS) are taken from the original development and validation of the Low Anterior Resection Syndrome score paper, Emmertsen et al, Aarhus, Denmark

The LARS questions are shown below and the points allocated are shown in red.

Please note that the predicted score is a single value based on the ‘average’ person. However the affect of bowel dysfunction on quality of life is highly individual. We have described this previously (3) and we have developed a, traffic light based, people diagram to try to represent scenario based variations in bowel related quality of life, as displayed below.

 

The LARS Questionnaire and Scoring Summary

The aim of this questionnaire is to assess your bowel function. Please tick only one box for each question. It may be difficult to select only one answer, as we know that for some patients symptoms vary from day to day. We would kindly ask you to choose one answer which best describes your daily life. If you have recently had an infection affecting your bowel function, please do not take this into account and focus on answering questions to reflect your usual daily bowel function.

Q.1 : Do you ever have occasions when you cannot control your flatus (wind)?

□ No, never 0
□ Yes, less than once per week 4
□ Yes, at least once per week 7

 

Q.2 : Do you ever have any accidental leakage of liquid stool?

□ No, never 0
□ Yes, less than once per week 3
□ Yes, at least once per week 3

 

Q.3 : How often do you open your bowels?

□ More than 7 times per day (24 hours) 4
□ 4-7 times per day (24 hours) 2
□ 1-3 times per day (24 hours) 0
□ Less than once per day (24 hours) 5

 

Q.4 : Do you ever have to open your bowels again within one hour of the last bowel opening?

□ No, never 0
□ Yes, less than once per week 9
□ Yes, at least once per week 11

 

Q.5 : Do you ever have such a strong urge to open your bowels that you have to rush to the toilet?

□ No, never 0
□ Yes, less than once per week 11
□ Yes, at least once per week 16

 

The allocated points per question are indicated in the right hand column, the score from each of the five answers is added together to give a final score between 0-42.

Interpretation:

0-20 = No LARS 21-29 = Minor LARS 30-42 = Major LARS

 

A consent aid that highlights the risk of impaired bowel-related quality of life (BQoL) after a restorative rectal cancer resection.

The 2 key risk factors are preoperative radiotherapy and tumor height ≤6 cm from the anal verge. BQoL is trichotomized into major, minor, or no impairment. The predicted percentages are derived from the multifactorial regression model (3).

Stay in touch

Sign up to hear from us
Donate Now

© 2023 Pelican Cancer Foundation - all rights reserved

  Registered Charity Number: 1141911 -  Privacy Policy